Although proteasome inhibitors such as carfilzomib have been reported to induce cell death in DLBCL cells combining with HDAC (histone deacetylase) inhibitors20, the effect of GA on DLBCL remains unknown. Here, HDAC9 is linked to diffuse large B-cell lymphoma.